Marker Therapeutics logo

Marker Therapeutics

MRKR | NASDAQ
Chart Builder DCF Calculator
$0.83
-$0.04 (-4.60%)
At close: Nov 16, 2026, 4:00 PM ET
$0.82
-$0.01 (-1.07%)
After-hours: Nov 16, 2026, 4:43 PM ET
-4.60%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
23
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #966/1021 (Top 95%)

Key Statistics

Market Data

Market Cap $16.03M
1D Range
0.82 0.91
52W Range
0.82 2.19

Valuation (TTM)

PE -1.73
PB 1.32
EV/EBITDA -0.54

Valuation (NTM)

Forward PE N/A
Forward PEG -0.04
Price Target $0.00
Loading financial charts...

Profile

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-...

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Jul 16, 2002
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.